當前位置: 首頁 SCI期刊 SCIE期刊 醫學 中科院1區 JCRQ1 期刊介紹(非官網)
        Jnci-journal Of The National Cancer Institute

        Jnci-journal Of The National Cancer InstituteSCIE

        國際簡稱:J NATL CANCER I  參考譯名:美國國家癌癥研究所Jnci雜志

        • 中科院分區

          1區

        • CiteScore分區

          Q1

        • JCR分區

          Q1

        基本信息:
        ISSN:0027-8874
        E-ISSN:1460-2105
        是否OA:未開放
        是否預警:否
        TOP期刊:是
        出版信息:
        出版地區:UNITED STATES
        出版商:Oxford University Press
        出版語言:English
        出版周期:Semimonthly
        出版年份:1940
        研究方向:ONCOLOGY
        評價信息:
        影響因子:9.9
        H-index:333
        CiteScore指數:17
        SJR指數:4.986
        SNIP指數:2.556
        發文數據:
        Gold OA文章占比:31.79%
        研究類文章占比:94.54%
        年發文量:183
        自引率:0.0291...
        開源占比:0.2626
        出版撤稿占比:0
        出版國人文章占比:0.03
        OA被引用占比:0.2637...
        英文簡介 期刊介紹 CiteScore數據 中科院SCI分區 JCR分區 發文數據 常見問題

        英文簡介Jnci-journal Of The National Cancer Institute期刊介紹

        The Journal of the National Cancer Institute publishes peer-reviewed original research from around the world and is internationally acclaimed as the source for the most up-to-date news and information from the rapidly changing fields of cancer research and treatment. For the past several years, the JNCI has been ranked as one of the most-cited original-research cancer journals by the Institute of Scientific Information in its annual Journal Citation Reports.

        期刊簡介Jnci-journal Of The National Cancer Institute期刊介紹

        《Jnci-journal Of The National Cancer Institute》自1940出版以來,是一本醫學優秀雜志。致力于發表原創科學研究結果,并為醫學各個領域的原創研究提供一個展示平臺,以促進醫學領域的的進步。該刊鼓勵先進的、清晰的闡述,從廣泛的視角提供當前感興趣的研究主題的新見解,或審查多年來某個重要領域的所有重要發展。該期刊特色在于及時報道醫學領域的最新進展和新發現新突破等。該刊近一年未被列入預警期刊名單,目前已被權威數據庫SCIE收錄,得到了廣泛的認可。

        該期刊投稿重要關注點:

        Cite Score數據(2024年最新版)Jnci-journal Of The National Cancer Institute Cite Score數據

        • CiteScore:17
        • SJR:4.986
        • SNIP:2.556
        學科類別 分區 排名 百分位
        大類:Medicine 小類:Oncology Q1 28 / 404

        93%

        大類:Medicine 小類:Cancer Research Q1 21 / 230

        91%

        CiteScore 是由Elsevier(愛思唯爾)推出的另一種評價期刊影響力的文獻計量指標。反映出一家期刊近期發表論文的年篇均引用次數。CiteScore以Scopus數據庫中收集的引文為基礎,針對的是前四年發表的論文的引文。CiteScore的意義在于,它可以為學術界提供一種新的、更全面、更客觀地評價期刊影響力的方法,而不僅僅是通過影響因子(IF)這一單一指標來評價。

        歷年Cite Score趨勢圖

        中科院SCI分區Jnci-journal Of The National Cancer Institute 中科院分區

        中科院 2023年12月升級版 綜述期刊:否 Top期刊:是
        大類學科 分區 小類學科 分區
        醫學 1區 ONCOLOGY 腫瘤學 1區

        中科院分區表 是以客觀數據為基礎,運用科學計量學方法對國際、國內學術期刊依據影響力進行等級劃分的期刊評價標準。它為我國科研、教育機構的管理人員、科研工作者提供了一份評價國際學術期刊影響力的參考數據,得到了全國各地高校、科研機構的廣泛認可。

        中科院分區表 將所有期刊按照一定指標劃分為1區、2區、3區、4區四個層次,類似于“優、良、及格”等。最開始,這個分區只是為了方便圖書管理及圖書情報領域的研究和期刊評估。之后中科院分區逐步發展成為了一種評價學術期刊質量的重要工具。

        歷年中科院分區趨勢圖

        JCR分區Jnci-journal Of The National Cancer Institute JCR分區

        2023-2024 年最新版
        按JIF指標學科分區 收錄子集 分區 排名 百分位
        學科:ONCOLOGY SCIE Q1 28 / 322

        91.5%

        按JCI指標學科分區 收錄子集 分區 排名 百分位
        學科:ONCOLOGY SCIE Q1 23 / 322

        93.01%

        JCR分區的優勢在于它可以幫助讀者對學術文獻質量進行評估。不同學科的文章引用量可能存在較大的差異,此時單獨依靠影響因子(IF)評價期刊的質量可能是存在一定問題的。因此,JCR將期刊按照學科門類和影響因子分為不同的分區,這樣讀者可以根據自己的研究領域和需求選擇合適的期刊。

        歷年影響因子趨勢圖

        發文數據

        2023-2024 年國家/地區發文量統計
        • 國家/地區數量
        • USA467
        • Canada81
        • England60
        • Australia52
        • France52
        • Netherlands52
        • GERMANY (FED REP GER)51
        • CHINA MAINLAND38
        • Italy34
        • Belgium29

        本刊中國學者近年發表論文

        • 1、DNA methylation profile in CpG-depleted regions uncovers a high-risk subtype of early-stage colorectal cancer

          Author: Yu, Huichuan; Wang, Xiaolin; Bai, Liangliang; Tang, Guannan; Carter, Kelly T.; Cui, Ji; Huang, Pinzhu; Liang, Li; Ding, Yanqing; Cai, Muyan; Huang, Meijin; Liu, Huanliang; Cao, Guangwen; Gallinger, Steven; Pai, Rish K.; Buchanan, Daniel D.; Win, Aung Ko; Newcomb, Polly A.; Wang, Jianping; Grady, William M.; Luo, Yanxin

          Journal: JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE. 2023; Vol. 115, Issue 1, pp. 52-61. DOI: 10.1093/jnci/djac183

        • 2、Design and reporting of phase III oncology trials with prospective biomarker validation

          Author: Liang, Fei; Peng, Ling; Wu, Zhengyu; Giamas, Georgios; Stebbing, Justin

          Journal: JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE. 2023; Vol. 115, Issue 2, pp. 174-180. DOI: 10.1093/jnci/djac210

        • 3、Ultra-processed food consumption and risk of colorectal cancer precursors: results from 3 prospective cohorts

          Author: Hang, Dong; Wang, Lu; Fang, Zhe; Du, Mengxi; Wang, Kai; He, Xiaosheng; Khandpur, Neha; Rossato, Sinara L.; Wu, Kana; Hu, Zhibin; Shen, Hongbing; Ogino, Shuji; Chan, Andrew T.; Giovannucci, Edward L.; Zhang, Fang Fang; Song, Mingyang

          Journal: JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE. 2023; Vol. 115, Issue 2, pp. 155-164. DOI: 10.1093/jnci/djac221

        • 4、Risk prediction models for endometrial cancer: development and validation in an international consortium

          Author: Shi, Joy; Kraft, Peter; Rosner, Bernard A.; Benavente, Yolanda; Black, Amanda; Brinton, Louise A.; Chen, Chu; Clarke, Megan A.; Cook, Linda S.; Costas, Laura; Dal Maso, Luigino; Freudenheim, Jo L.; Frias-Gomez, Jon; Friedenreich, Christine M.; Garcia-Closas, Montserrat; Goodman, Marc T.; Johnson, Lisa; La Vecchia, Carlo; Levi, Fabio; Lissowska, Jolanta; Lu, Lingeng; McCann, Susan E.; Moysich, Kirsten B.; Negri, Eva; O'Connell, Kelli; Parazzini, Fabio; Petruzella, Stacey; Polesel, Jerry; Ponte, Jeanette; Rebbeck, Timothy R.; Reynolds, Peggy; Ricceri, Fulvio; Risch, Harvey A.; Sacerdote, Carlotta; Setiawan, Veronica W.; Shu, Xiao-Ou; Spurdle, Amanda B.; Trabert, Britton; Webb, Penelope M.; Wentzensen, Nicolas; Wilkens, Lynne R.; Xu, Wang Hong; Yang, Hannah P.; Yu, Herbert; Du, Mengmeng; De Vivo, Immaculata

          Journal: JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE. 2023; Vol. , Issue , pp. -. DOI: 10.1093/jnci/djad014

        • 5、Recommendations for Epstein-Barr virus-based screening for nasopharyngeal cancer in high- and intermediate-risk regions

          Author: Lam, W. K. Jacky; King, Ann D.; Miller, Jacob A.; Liu, Zhiwei; Yu, Kelly J.; Chua, Melvin L. K.; Ma, Brigette B. Y.; Chen, Ming Yuan; Pinsky, Benjamin A.; Lou, Pei-Jen; Woo, John K. S.; Hsu, Wan-Lun; Simon, Julia; Doolan, Denise L.; Waterboer, Tim; Hui, Edwin P.; Li, Hui; Tsang, Raymond K.; Wong, Kenneth C. W.; Goh, Julian P.; Vlantis, Alexander C.; Ai, Qi Yong; Wong, Lun M.; Abdullah, Victor; Lin, Jin Ching; Chen, Chien-Jen; Pfeiffer, Ruth M.; Le, Quynh-Thu; Lee, Anne W. M.; Ji, Mingfang; Cao, Sumei; Ma, Jun; Chan, Anthony T. C.; Chan, K. C. Allen; Hildesheim, Allan

          Journal: JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE. 2023; Vol. 115, Issue 4, pp. 355-364. DOI: 10.1093/jnci/djad012

        • 6、Molecular profiling and treatment pattern differences between intrahepatic and extrahepatic cholangiocarcinoma

          Author: Spencer, Kristen; Pappas, Leontios; Baiev, Islam; Maurer, Jordan; Bocobo, Andrea Grace; Zhang, Karen; Jain, Apurva; De Armas, Anaemy Danner; Reyes, Stephanie; Le, Tri Minh; Rahma, Osama E.; Stanton, Jennifer; DeLeon, Thomas T.; Roth, Marc; Peters, Mary Linton B.; Zhu, Andrew X.; Lennerz, Jochen K.; Iafrate, A. John; Boyhen, Kylie; VanCott, Christine; Roberts, Lewis R.; Lindsey, Stacie; Horick, Nora; Goff, Laura Williams; Mody, Kabir; Borad, Mitesh J.; Shroff, Rachna T.; Kelley, Robin Kate; Javle, Milind M.; Goyal, Lipika

          Journal: JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE. 2023; Vol. , Issue , pp. -. DOI: 10.1093/jnci/djad046

        • 7、Adjuvant Anti-HER2 Therapy, Treatment-Related Amenorrhea, and Survival in Premenopausal HER2-Positive Early Breast Cancer Patients.

          Author: Lambertini M1, Campbell C2, Bines J, Korde LA3, Izquierdo M4, Fumagalli D5, Del Mastro L6, Ignatiadis M1, Pritchard K7, Wolff AC8, Jackisch C9, Lang I10, Untch M11, Smith I12, Boyle F13, Xu B14, Barrios CH15, Baselga J16,17, Moreno-Aspitia A18, Piccart M1, Gelber RD19, de Azambuja E1.

          Journal: J Natl Cancer Inst. 2019 Jan 1;111(1):86-94. doi: 10.1093/jnci/djy094.

        • 8、Novel Common Genetic Susceptibility Loci for Colorectal Cancer.

          Author: Schmit SL1,2, Edlund CK2, Schumacher FR3, Gong J4, Harrison TA4, Huyghe JR4, Qu C2,4, Melas M2, Van Den Berg DJ2, Wang H5, Tring S2,6,7, Plummer SJ8, Albanes D9, Alonso MH10,11,12, Amos CI13, Anton K13, Aragaki AK4, Arndt V14, Barry EL15, Berndt SI9, Bezieau S4, Bien S16, Bloomer A1, Boehm J17, Boutron-Ruault MC18,19, Brenner H14,20,21, Brezina S22, Buchanan DD23,24,25, Butterbach K14, Caan BJ26, Campbell PT27, Carlson CS4, Castelao JE28, Chan AT29,30, Chang-Claude J31,32,33, Chanock SJ9, Cheng I34, Cheng YW35, Chin LS36, Church JM37, Church T38, Coetzee GA39, Cotterchio M40, Cruz Correa M41, Curtis KR4, Duggan D42, Easton DF43, English D44, Feskens EJM45, Fischer R46, FitzGerald LM44,47, Fortini BK48, Fritsche LG49,50, Fuchs CS51,52, Gago-Dominguez M53,54, Gala M29, Gallinger SJ55, Gauderman WJ2, Giles GG23,44, Giovannucci EL32,56, Gogarten SM57, Gonzalez-Villalpando C58, Gonzalez-Villalpando EM59, Grady WM60, Greenson JK61, Gsur A62, Gunter M30, Haiman CA2, Hampe J63, Harlid S64, Harju JF46, Hayes RB65, Hofer P62, Hoffmeister M14, Hopper JL66, Huang SC2, Huerta JM67, Hudson TJ68,69, Hunter DJ70, Idos GE2, Iwasaki M71, Jackson RD72, Jacobs EJ27, Jee SH73, Jenkins MA23, Jia WH74, Jiao S4, Joshi AD30,70, Kolonel LN75, Kono S22, Kooperberg C4, Krogh V76, Kuehn T77, Küry S78, LaCroix A4, Laurie CA57, Lejbkowicz F1, Lemire M69, Lenz HJ2,79, Levine D57, Li CI80, Li L81, Lieb W82, Lin Y4, Lindor NM83, Liu YR84, Loupakis F35, Lu Y85, Luh F86, Ma J87, Mancao C88, Manion FJ46, Markowitz SD89, Martin V90, Matsuda K91, Matsuo K92,93, McDonnell KJ2, McNeil CE2, Milne R23,44, Molina AJ11,94, Mukherjee B46, Murphy N95, Newcomb PA4, Offit K96, Omichessan H18,19, Palli D97, Cotoré JPP98, Pérez-Mayoral J99, Pharoah PD100, Potter JD4, Qu C2,4, Raskin L85,91, Rennert G86,101,102, Rennert HS86,101, Riggs BM1, Schafmayer C103, Schoen RE104, Sellers TA1, Seminara D105, Severi G18,106, Shi W107, Shibata D108, Shu XO85,91, Siegel EM1, Slattery ML109, Southey M24, Stadler ZK96,110, Stern MC2, Stintzing S111, Taverna D112, Thibodeau SN113, Thomas DC2, Trichopoulou A114, Tsugane S2,6,7, Ulrich CM17, van Duijnhoven FJB45, van Guelpan B, Vijai J96, Virtamo J115, Weinstein SJ9, White E4, Win AK23, Wolk A116, Woods M117, Wu AH2, Wu K118, Xiang YB119, Yen Y35,120, Zanke BW121,122, Zeng YX74, Zhang B123, Zubair N4, Kweon SS124,125, Figueiredo JC126,127, Zheng W85,91, Marchand LL5, Lindblom A128, Moreno V10,11,12, Peters U129, Casey G8, Hsu L4, Conti DV2, Gruber SB2,79.

          Journal: J Natl Cancer Inst. 2019 Feb 1;111(2):146-157. doi: 10.1093/jnci/djy099.

        投稿常見問題

        通訊方式:JOURNALS DEPT, 2001 EVANS RD, CARY, USA, NC, 27513。

        主站蜘蛛池模板: 鲁丝片一区二区三区免费| 亚洲av无码一区二区三区天堂| 韩国美女vip福利一区| 风流老熟女一区二区三区| 国产午夜精品一区理论片| 日本一区中文字幕日本一二三区视频 | 久久精品视频一区二区三区| 国产成人av一区二区三区在线观看| 亚洲国产视频一区| 一区二区视频在线播放| 亚洲毛片αv无线播放一区| 国产成人精品一区二区三区| 日韩一区二区三区视频| 精彩视频一区二区| 国产成人片视频一区二区| 国产一区在线播放| 福利在线一区二区| 一区二区手机视频| 国产福利电影一区二区三区,亚洲国模精品一区 | AV天堂午夜精品一区| 四虎永久在线精品免费一区二区| 精品日韩一区二区| 国产一区二区三区在线免费 | 色国产在线视频一区| 国产熟女一区二区三区五月婷| 午夜视频在线观看一区二区| 精品国产一区二区三区香蕉事| 欧亚精品一区三区免费| 精品国产精品久久一区免费式 | 色国产在线视频一区| 在线视频亚洲一区| 亚洲高清偷拍一区二区三区| 精品久久久久一区二区三区| 国产亚洲综合一区柠檬导航| 国产成人无码一区二区在线播放| 无码人妻精品一区二区三18禁| 亚洲午夜一区二区电影院| 日本一区二三区好的精华液| 全国精品一区二区在线观看| 中文字幕一区二区三区在线播放 | 中文字幕在线一区二区三区|